ONC

BEONE MEDICINES LTD.

ONC · CIK 1651308 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$5.3B
20182025
Net Income$0.3B
20182025
Operating CF$1.1B
20182025
Free Cash Flow$0.9B
20182025

Income Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Revenue$5.3B$3.8B$2.5B$1.4B$0.1B$0.1B$0.1B
Cost of Revenue$0.3B$0.2B$0.1B$0.1B$0.0B
Gross Profit$4.7B$3.2B$2.1B
R&D Expense$2.1B$2.0B$1.8B$1.6B$1.5B$1.3B$0.9B$0.7B
SG&A Expense$2.1B$1.8B$1.5B$1.3B$1.0B$0.6B$0.4B$0.2B
Operating Income$0.4B$-0.6B$-1.2B$-1.8B$-1.4B$-0.5B$-0.4B$-0.3B
Net Income$0.3B$-0.6B$-0.9B$-2.0B$-1.4B$-0.5B$-0.4B$-0.3B
EPS (Basic)$0.20$-0.47$-0.65$-1.49$-1.17$-0.35
EPS (Diluted)$0.19$-0.47$-0.65$-1.49$-1.17$-0.17

Balance Sheet

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Total Assets$8.2B$5.9B$5.8B$6.4B$8.6B$5.6B$1.6B$2.2B
Current Assets$6.2B$4.0B$4.2B$5.2B$7.6B$5.0B$1.2B$1.9B
Cash & Equivalents$4.5B$2.6B$3.2B$3.9B$4.4B$1.4B$0.6B$0.7B
Total Liabilities$3.8B$2.6B$2.3B$2.0B$2.4B$1.7B$0.6B$0.5B
Current Liabilities$1.8B$2.2B$1.8B$1.5B$1.6B$1.1B$0.3B$0.2B
Stockholders' Equity$4.4B$3.3B$3.5B$4.4B$6.2B$3.9B$1.0B$1.7B

Cash Flow Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Operating Cash Flow$1.1B$-0.1B$-1.2B$-1.5B$-1.3B$-1.3B$-0.8B$-0.5B
Investing Cash Flow$-0.3B$-0.5B$0.1B$1.1B$0.6B$-3.2B$0.6B$-0.6B
Capital Expenditures$0.2B$0.5B$0.6B$0.3B$0.3B$0.1B$0.1B$0.1B
Financing Cash Flow$1.1B$0.2B$0.4B$-0.0B$3.6B$5.2B$0.1B$1.7B